Article

15 Abstracts at ASCO Quality Care Symposium Highlight Work From OneOncology Practices

The abstracts address the latest research addressing clinical innovation, care delivery, health equity, clinical trial diversity, measuring patient and caregiver experience, provider efficiency, clinical outcomes, quality care, and safety in oncology.

Nashville, September 15, 2022 – OneOncology, the national platform for leading independent oncology practices, announced today that physician researchers affiliated with OneOncology partner practices will have 15 abstracts presented at the upcoming ASCO Quality Care Symposium September 30 through October 1.

Tennessee Oncology researchers will have 9 abstracts presented while 3 abstracts presented include Astera Cancer Care, 2 abstracts presented include researchers from West Cancer Center and Research Institute, and 1 abstract includes researchers from The Center for Cancer and Blood Disorders in Fort Worth, Texas.

The abstracts address the latest research addressing clinical innovation, care delivery, health equity, clinical trial diversity, measuring patient and caregiver experience, provider efficiency, clinical outcomes, quality care, and safety in oncology.

“These abstracts evidence some of the most important research advancing equity, quality and care delivery and affordability in cancer care today,” said Davey Daniel, MD, Chief Medical Officer, OneOncology. “I’m excited to see how the research presented at the Quality Care Symposium will impact cancer care, and just as excited to discuss it with physician colleagues from across OneOncology.”

For a full listing of the abstracts, click here.


Related Videos
Neil Goldfarb, GPBCH
Dr Bonnie Qin
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
dr carol regueiro
dr carol regueiro
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Mabel Mardones, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo